Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO - PubMed (original) (raw)
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO
Maria L Belladonna et al. J Immunol. 2006.
Abstract
Dendritic cell (DC) tryptophan catabolism has emerged in recent years as a major mechanism of peripheral tolerance. However, there are features of this mechanism, initiated by IDO, that are still unclear, including the role of enzymes that are downstream of IDO in the kynurenine pathway and the role of the associated production of kynurenines. In this study, we provide evidence that 1) murine DCs express all enzymes necessary for synthesis of the downstream product of tryptophan breakdown, quinolinate; 2) IFN-gamma enhances transcriptional expression of all of these enzymes, although posttranslational inactivation of IDO may prevent metabolic steps that are subsequent and consequent to IDO; 3) overcoming the IDO-dependent blockade by provision of a downstream quinolinate precursor activates the pathway and leads to the onset of suppressive properties; and 4) tolerogenic DCs can confer suppressive ability on otherwise immunogenic DCs across a Transwell in an IDO-dependent fashion. Altogether, these data indicate that kynurenine pathway enzymes downstream of IDO can initiate tolerogenesis by DCs independently of tryptophan deprivation. The paracrine production of kynurenines might be one mechanism used by IDO-competent cells to convert DCs lacking functional IDO to a tolerogenic phenotype within an IFN-gamma-rich environment.
Similar articles
- Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML, Puccetti P, Orabona C, Fallarino F, Vacca C, Volpi C, Gizzi S, Pallotta MT, Fioretti MC, Grohmann U. Belladonna ML, et al. Transplantation. 2007 Jul 15;84(1 Suppl):S17-20. doi: 10.1097/01.tp.0000269199.16209.22. Transplantation. 2007. PMID: 17632406 - Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.
Orabona C, Puccetti P, Vacca C, Bicciato S, Luchini A, Fallarino F, Bianchi R, Velardi E, Perruccio K, Velardi A, Bronte V, Fioretti MC, Grohmann U. Orabona C, et al. Blood. 2006 Apr 1;107(7):2846-54. doi: 10.1182/blood-2005-10-4077. Epub 2005 Dec 8. Blood. 2006. PMID: 16339401 - Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C, Grohmann U. Orabona C, et al. Methods Mol Biol. 2011;677:269-80. doi: 10.1007/978-1-60761-869-0_19. Methods Mol Biol. 2011. PMID: 20941617 - Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR, Nikolic-Paterson DJ. Mulley WR, et al. Nephrology (Carlton). 2008 Jun;13(3):204-11. doi: 10.1111/j.1440-1797.2007.00921.x. Epub 2008 Jan 23. Nephrology (Carlton). 2008. PMID: 18221253 Review. - Regulation of expression and function of IDO in human dendritic cells.
Heitger A. Heitger A. Curr Med Chem. 2011;18(15):2222-33. doi: 10.2174/092986711795656018. Curr Med Chem. 2011. PMID: 21517757 Review.
Cited by
- Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer.
Sarangi P. Sarangi P. Cancer Pathog Ther. 2023 Nov 7;2(4):246-255. doi: 10.1016/j.cpt.2023.11.001. eCollection 2024 Oct. Cancer Pathog Ther. 2023. PMID: 39371092 Free PMC article. Review. - Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin-9 dependent mechanism.
Lefebvre A, Trioën C, Renaud S, Laine W, Hennart B, Bouchez C, Leroux B, Allorge D, Kluza J, Werkmeister E, Grolez GP, Delhem N, Moralès O. Lefebvre A, et al. J Extracell Vesicles. 2023 Dec;12(12):e12390. doi: 10.1002/jev2.12390. J Extracell Vesicles. 2023. PMID: 38117000 Free PMC article. - The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy.
Badawy AA. Badawy AA. Biosci Rep. 2023 Aug 31;43(8):BSR20230595. doi: 10.1042/BSR20230595. Biosci Rep. 2023. PMID: 37486805 Free PMC article. - PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions.
Walczak K, Gerkowicz A, Krasowska D. Walczak K, et al. Int J Mol Sci. 2023 Feb 4;24(4):3114. doi: 10.3390/ijms24043114. Int J Mol Sci. 2023. PMID: 36834531 Free PMC article. Review. - An integrated cytokine and kynurenine network as the basis of neuroimmune communication.
Stone TW, Clanchy FIL, Huang YS, Chiang NY, Darlington LG, Williams RO. Stone TW, et al. Front Neurosci. 2022 Nov 24;16:1002004. doi: 10.3389/fnins.2022.1002004. eCollection 2022. Front Neurosci. 2022. PMID: 36507331 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials